CHROMITOPE SODIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Chromitope Sodium is an injectable diagnostic radiopharmaceutical approved in 1971 by Bracco for diagnostic imaging purposes. The drug's specific mechanism of action and indications are not publicly detailed in available data, but its long market history suggests established clinical utility in nuclear medicine imaging. It represents an older generation of diagnostic agents in the radiopharmaceutical class.
LOE Approaching
Product is in late-stage lifecycle with modest competitive pressure (30/100), suggesting a stable but mature team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Chromitope Sodium offers stable, maintenance-oriented career experience in a legacy diagnostic product with minimal job openings and growth opportunities. This role is best suited for professionals seeking to master operational excellence and customer relationship management in a mature product portfolio rather than launching or scaling innovations.
Product Manager
Worked on CHROMITOPE SODIUM at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.